絞り込み

16643

広告

ノーベル化学賞の吉野さん 理事長務める大阪の研究施設に出勤

ノーベル化学賞に選ばれた吉野彰さんが、受賞決定後初めて、自身が理事長を務める大阪府内のリチウムイオン電池の研究施設に出勤し、研究への変わらぬ意欲を示しました。

  1. [医学] ICU患者への控えめな酸素供給...
  2. 移植不適格な新規診断多発性骨髄腫へのD-...
  3. 移植不適格な新規診断多発性骨髄腫に対して...
  4. 「イクメン企業アワード2019」・「イク...

ニュース一覧

Fusion of Large-Scale Genomic Knowledge and Frequency Data Computationally Prioritizes Variants in Epilepsy.

著者 Campbell IM , Rao M , Arredondo SD , Lalani SR , Xia Z , Kang SH , Bi W , Breman AM , Smith JL , Bacino CA , Beaudet AL , Patel A , Cheung SW , Lupski JR , Stankiewicz P , Ramocki MB , Shaw CA
PLoS Genet.2013 Sep ; 9(9):e1003797.
この記事をPubMed上で見るPubMedで表示
この記事をGoogle翻訳上で見る Google翻訳で開く

Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America.

スターを付ける スターを付ける     (6view , 0users)

Full Text Sources

Medical

Curation and interpretation of copy number variants identified by genome-wide testing is challenged by the large number of events harbored in each personal genome. Conventional determination of phenotypic relevance relies on patterns of higher frequency in affected individuals versus controls; however, an increasing amount of ascertained variation is rare or private to clans. Consequently, frequency data have less utility to resolve pathogenic from benign. One solution is disease-specific algorithms that leverage gene knowledge together with variant frequency to aid prioritization. We used large-scale resources including Gene Ontology, protein-protein interactions and other annotation systems together with a broad set of 83 genes with known associations to epilepsy to construct a pathogenicity score for the phenotype. We evaluated the score for all annotated human genes and applied Bayesian methods to combine the derived pathogenicity score with frequency information from our diagnostic laboratory. Analysis determined Bayes factors and posterior distributions for each gene. We applied our method to subjects with abnormal chromosomal microarray results and confirmed epilepsy diagnoses gathered by electronic medical record review. Genes deleted in our subjects with epilepsy had significantly higher pathogenicity scores and Bayes factors compared to subjects referred for non-neurologic indications. We also applied our scores to identify a recently validated epilepsy gene in a complex genomic region and to reveal candidate genes for epilepsy. We propose a potential use in clinical decision support for our results in the context of genome-wide screening. Our approach demonstrates the utility of integrative data in medical genomics.
PMID: 24086149 [PubMed - as supplied by publisher]
印刷用ページを開く Endnote用テキストダウンロード